Eric Halioua
@HaliouaEric
Followers
213
Following
2K
Media
82
Statuses
768
Serial entrepreneur in #celltherapy #genetherapy & #Biotechnology. President-CEO PDC*Line Pharma #Entrepreneurship #Leadership #VC
Bruxelles, Belgique
Joined March 2014
-> Don’t miss this article!.
In this interview, Eric Halioua reflects on the start, success and momentum of PDC*line Pharma, a clinical-stage biotechnology company developing allogeneic cellular immunotherapies for cancer. He also shares three top tips for start-up companies on their investment and funding
0
0
1
RT @RegMedNet: In this interview, Eric Halioua reflects on the start, success and momentum of PDC*line Pharma, a clinical-stage biotechnolo….
0
2
0
RT @HaliouaEric: Excited to be part of the 25th #BioEquityEurope Presenting Company Class of 2025 next week in Bruges, Belgium!.This year’s….
0
2
0
Excited to be part of the 25th #BioEquityEurope Presenting Company Class of 2025 next week in Bruges, Belgium!.This year’s theme — “Can European biotech rise to the complexity of the moment?” — couldn’t be more timely. 📅 Learn more:
0
2
3
👉 New Video following poster presentation at the European Lung Cancer Congress 2025 #ELCC2025 21P PDC*lung01 cancer vaccine. We are pleased to share a video presentation by Prof. Dr. Johan Vansteenkiste, the principal investigator of our clinical trial.
0
0
0
RT @oncodaily: Highlights from ELCC Day 3. @alessandra_dodi @Alfdoc2 @SuyogCancer @Tony_Calles @HaliouaEric @g_mountzios @NReguart @Dr_Ivan….
0
5
0
PDC*line Pharma Unveils New Clinical Results with PDC*lung01 at the #ELCC2025 . Poster Title: Primary analysis of safety, efficacy and immunogenicity of the therapeutic cancer vaccine PDClung01 with or without pembrolizumab in NSCLC: A multicenter phase I/II study
0
0
2
Exciting news! Our abstract has been accepted for a poster presentation at #ELCC2025. We’re proud to share new data from our ongoing clinical development program with PDC*lung01, our therapeutic cancer vaccine NSCLC.
lnkd.in
This link will take you to a page that’s not on LinkedIn
0
0
4
Tomorrow’s the day! I’m excited to be speaking at Advanced Therapies UK 2025, where industry leaders will meet for two days of insightful discussions, networking, and innovation. There’s still time to join us in London—don’t miss out. #adtherapies
i.snoball.it
The Advanced Therapies Congress brings together speakers from across the entire value chain of cell and gene therapy development
0
0
1
I’m thrilled to be attending the J.P. Morgan Conference in San Francisco from Sunday to Wednesday evening. If you’re attending as well and would like to connect, feel free to reach out or meet me at the conference. Looking forward to dynamic discussions in this hub of innovation!
0
1
3
I’m thrilled to be hosting an Executive Roundtable at @WuXi_AppTec #WuXiGlobalForum during #JPM2025!.I’m excited to discuss about opportunities of innovative cancer vaccines ! Learn more about the event here:
0
0
1
We are thrilled to share the primary clinical results from our Phase I/II trial of the PDC*lung01 cancer vaccine, presented at ESMO-IO 2024! PDC*lung01, combined with pembro, shows potential for meaningful clinical benefit compared to pembro alone in stage IV NSCLC patients.
1
0
1
New Article Featuring CEO of @pdc_line Published in @BioprocessIC Interview provides valuable insights into the driving force behind our innovative platform, the resilience required to thrive in the industry, and the transformative role of global partnerships in our success.
0
1
3
RT @pdc_line: New Article Featuring Our CEO @HaliouaEric Published in @BioprocessIC Eric provides valuable insights into the driving forc….
0
1
0
We are thrilled to announce that we have been selected for an oral presentation at the “Educational Days” of the SFHI, held in Strasbourg from October 9 to 11, 2024!🔗 Learn more about the event: ttps://lnkd.in/gz5SQndR
0
0
2
Sciences de la vie en Belgique : la réindustrialisation du secteur est une priorité!.
fr.planet-future.be
Les life sciences englobent de nombreuses spécialités : biotechnologies, chimie, pharmaceutique, dispositifs médicaux, etc.
0
0
2
I am delighted to announce that we made an oral presentation at the International Session of the 50th Annual Meeting of Korean Cancer Association! After the AACR, CIMT and EIF annual conferences, it is the 4th oral presentation in an prestigious scientific conference this year!
0
0
1